On Apr. 8, 2026, the Trump administration will not be asking the Supreme Court to take up its…
On Apr. 7, 2026, Gilead Sciences announced it has entered into a definitive agreement to acquire Tubulis, a…
On Apr. 7, 2026, Cornell scientists announce they have taken a major step toward developing a safe, reversible,…
On Apr. 7, 2026, LifeScienceHistory.com, formerly WashingtonLifeScience.com, announces release of a report highlighting the challenges of Washington State’s…
On Apr. 6, 2026, scientists from the University of California, Los Angeles (UCLA) announce they have developed a…
On Apr. 2, 2026, Zhang Kai, a rising cryo-electron microscopy researcher, has resigned from his tenure-track position at…
On Apr. 1, 2026, a research team at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of…
On Apr. 1, 2026, Eli Lilly announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for…
On Mar. 31, 2026, the Organisation for Economic Co-operation and Development (OECD), reports that China has officially crept…
On Mar. 31, 2026, Biogen and Apellis Pharmaceuticals announced the companies have entered into a definitive agreement under…
On Mar. 31, 2026, Eli Lilly and Centessa Pharmaceuticals, a clinical-stage company developing a new class of medicines…
On Mar. 30, 2026, Biogen announced that the High Dose Regimen of SPINRAZA® (nusinersen), which is comprised of…
On Mar. 29, 2026, The South China Morning Post reported the cross-border outlicensing activities of Chinese biotech firms…
On Mar. 29, 2026, generative-AI drug developer Insilico Medicine announced that it has agreed to a global licensing…
On Mar. 27, 2026, a STAT survey conducted of nearly 1,000 National Institutes of Health (NIH) -supported scientists,…
On Mar. 27, 2026, Novartis announced an agreement to acquire Excellergy, a private biotech company developing next-generation anti-IgE…
On Mar. 27, 2026, A multi-institutional team of scientists, co-led by Northwestern University, has taken a crucial step…
On Mar. 27, 2026, measles cases in the United States have climbed to 1,575, with 88 new infections,…
On Mar. 27, 2026, Rocket Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has granted accelerated approval…
On Mar. 26, 2026, Indiana’s poultry industry continues to face significant challenges as outbreaks of highly pathogenic avian…
On Mar. 25, 2026, Merck, and Terns Pharmaceuticals, a clinical-stage oncology company, announced that the companies have entered…
On Mar. 25, 2026, researchers, led by scientists at the University of Yamanashi in Japan, cloned a single…
On Mar. 25, 2026, according to the latest data published by the World Health Organization (WHO), globally, 941,582…
On Mar. 24, 2026, researchers at the Francis Crick Institute report that the largest ancient DNA study of…
On Mar. 24, 2026, a study published in Nature describes how researchers are pulling clues from genetic material…
On Mar. 24, 2026, Governor Brian P. Kemp announced that global biopharmaceutical giant UCB, is planning a significant…
On Mar. 24, 2026, Pfizer and Valneva announced topline results from the Phase 3 VALOR “Vaccine Against Lyme…
On Mar. 23, 2026, Wilmington PharmaTech, a leading U.S.-based research, development, and manufacturing organization (CRDMO) focused on complex…
On Mar. 23, 2026, it was reported that since the beginning of March, highly pathogenic avian influenza has…
On Mar. 20, 2026, Novartis announced an agreement with Synnovation Therapeutics, to acquire SNV4818, a pan-mutant‑selective PI3Kα inhibitor,…